Literature DB >> 19041374

Epidermal growth factor administered in the periphery influences excitatory synaptic inputs onto midbrain dopaminergic neurons in postnatal mice.

H Namba1, Y Zheng, Y Abe, H Nawa.   

Abstract

Epidermal growth factor (EGF) has a neurotrophic activity on developing midbrain dopaminergic neurons. We investigated developmental effects of peripheral EGF administration on dopaminergic neurons in midbrain slice preparations containing ventral tegmental area (VTA). Subcutaneous EGF administration to mouse neonates triggered phosphorylation of EGF receptors (ErbB1 and ErbB2) in the midbrain region, suggesting its penetration through the blood-brain barrier. We repeated EGF administration in postnatal mice and examined synaptic transmission in the VTA with electrophysiological recordings. Subchronic EGF treatment increased the amplitude of field excitatory postsynaptic potentials evoked by stimulation of the anterior VTA. To analyze the EGF effect at a single cell level, dopaminergic neurons were identified by their characteristic hyperpolarizing activated currents in whole cell recording. In these dopaminergic neurons, EGF effects the amplitude of spontaneous miniature excitatory postsynaptic currents (mEPSCs) without affecting their frequency. In agreement, EGF also enhanced the AMPA/NMDA ratio of evoked EPSCs in the dopaminergic neurons. In contrast, EGF effects on mEPSCs of neighboring neurons not exhibiting hyperpolarizing activated currents were modest or insignificant. Thus, these results suggest that circulating EGF substantially influences the physiological properties of developing midbrain dopaminergic neurons in perinatal and postnatal mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041374     DOI: 10.1016/j.neuroscience.2008.10.057

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  EGF Treatment Improves Motor Behavior and Cortical GABAergic Function in the R6/2 Mouse Model of Huntington's Disease.

Authors:  Felecia M Marottoli; Mercedes Priego; Eden Flores-Barrera; Rohan Pisharody; Steve Zaldua; Kelly D Fan; Giri K Ekkurthi; Scott T Brady; Gerardo A Morfini; Kuei Y Tseng; Leon M Tai
Journal:  Mol Neurobiol       Date:  2019-05-19       Impact factor: 5.590

2.  Central role of the EGF receptor in neurometabolic aging.

Authors:  Sana Siddiqui; Meng Fang; Bin Ni; Daoyuan Lu; Bronwen Martin; Stuart Maudsley
Journal:  Int J Endocrinol       Date:  2012-06-17       Impact factor: 3.257

3.  Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma.

Authors:  Mariska Sie; Wilfred F A den Dunnen; Harm Jan Lourens; Tiny G J Meeuwsen-de Boer; Frank J G Scherpen; Walderik W Zomerman; Kim R Kampen; Eelco W Hoving; Eveline S J M de Bont
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

4.  mGluR1-Dependent Long Term Depression in Rodent Midbrain Dopamine Neurons Is Regulated by Neuregulin 1/ErbB Signaling.

Authors:  Ada Ledonne; Nicola Biagio Mercuri
Journal:  Front Mol Neurosci       Date:  2018-10-01       Impact factor: 5.639

5.  Mechanism of saikogenin G against major depressive disorder determined by network pharmacology.

Authors:  Lili Hu; Jue Wang; Xiaoge Zhao; Donghui Cai
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

6.  ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease.

Authors:  Yuriko Iwakura; Hiroyuki Nawa
Journal:  Front Cell Neurosci       Date:  2013-02-13       Impact factor: 5.505

Review 7.  Neuropathologic implication of peripheral neuregulin-1 and EGF signals in dopaminergic dysfunction and behavioral deficits relevant to schizophrenia: their target cells and time window.

Authors:  Hiroyuki Nawa; Hidekazu Sotoyama; Yuriko Iwakura; Nobuyuki Takei; Hisaaki Namba
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

8.  Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines.

Authors:  Walderik W Zomerman; Sabine L A Plasschaert; Sander H Diks; Harm-Jan Lourens; Tiny Meeuwsen-de Boer; Eelco W Hoving; Wilfred F A den Dunnen; Eveline S J M de Bont
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

9.  Perinatal Exposure to Neuregulin-1 Results in Disinhibition of Adult Midbrain Dopaminergic Neurons: Implication in Schizophrenia Modeling.

Authors:  Hisaaki Namba; Takeshi Okubo; Hiroyuki Nawa
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

Review 10.  On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity.

Authors:  Ada Ledonne; Nicola B Mercuri
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.